Spectroscopic optical cohernece tomography for intravascular imaging

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$112,931.00
Award Year:
2008
Program:
SBIR
Phase:
Phase I
Contract:
1R43HL092690-01
Award Id:
89320
Agency Tracking Number:
HL092690
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
SOUTHWEST SCIENCES, INC., 1570 PACHECO ST, STE E-11, SANTA FE, NM, 87505
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
153579891
Principal Investigator:
KRISTEN PETERSON
(505) 984-1322
PETERSON@SWSCIENCES.COM
Business Contact:
() -
astanton@swsciences.com
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): The overall objective of this SBIR project is the development of a rapid, high resolution optical method for in vivo imaging with a specific emphasis on intravascular imaging and the identification of vulnerable plaque. The approach uses a novel harmonic detection method for optical coherence tomography (OCT) that will allow depth resolved near infrared spectroscopy in conjunction with structural imaging. Since different structures in atherosclerotic plaques, such as the fibrotic caps, lipid pools and calcifications have different near infrared spectroscopic features, spectroscopic OCT is a promising approach to enhancing contrast in optical coherence tomography. Southwest Sciences recently developed a harmonic detect ion method for optical coherence tomography for the removal of artifacts inherent to Fourier domain OCT, but the method can also be used to provide the phase information necessary for spectroscopic OCT. Harmonic detection is easily applied because it uses a simple sine- wave modulation of the interferometer, with detection at harmonics of the applied wave. Phase I of this project focuses on demonstrating spectroscopic OCT using our harmonic detection technology. In particular, a near infrared absorption feature of lipid, which is an important component of vulnerable atherosclerotic plaques, will be used to demonstrate contrast enhancement resulting from spectroscopic OCT. In Phase II, we will proceed with design and construction of a fiber-optic, cathete r probe instrument for intra-luminal imaging of arteries, with the goal of conducting Phase III clinical studies.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government